The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 34021074.
- Also identified by DOI 10.1073/pnas.2024202118 and PMC identifier 8201919.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global pandemic and has claimed over 2 million lives worldwide. Although the genetic sequences of SARS-CoV and SARS-CoV-2 have high homology, the clinical and pathological characteristics of COVID-19 differ significantly from those of SARS. How and whether SARS-CoV-2 evades (cellular) immune surveillance requires further elucidation. In this study, we show that SARS-CoV-2 infection leads to major histocompability complex class Ι (MHC-Ι) down-regulation both in vitro and in vivo. The viral protein encoded by open reading frame 8 (ORF8) of SARS-CoV-2, which shares the least homology with SARS-CoV among all viral proteins, directly interacts with MHC-Ι molecules and mediates their down-regulation. In ORF8-expressing cells, MHC-Ι molecules are selectively targeted for lysosomal degradation via autophagy. Thus, SARS-CoV-2-infected cells are much less sensitive to lysis by cytotoxic T lymphocytes. Because ORF8 protein impairs the antigen presentation system, inhibition of ORF8 could be a strategy to improve immune surveillance.
Medical subject headings
- Animals
- Antigen Presentation
- Autophagy
- Autophagy/genetics
- Autophagy/immunology
- COVID-19
- COVID-19/genetics
- COVID-19/immunology
- Chlorocebus aethiops
- Down-Regulation
- Down-Regulation/immunology
- HEK293 Cells
- Histocompatibility Antigens Class I
- Histocompatibility Antigens Class I/genetics
- Histocompatibility Antigens Class I/immunology
- Humans
- Immune Evasion
- Lysosomes
- Lysosomes/genetics
- Lysosomes/immunology
- Lysosomes/virology
- Mice
- Mice, Transgenic
- SARS-CoV-2
- SARS-CoV-2/genetics
- SARS-CoV-2/immunology
- Vero Cells
- Viral Proteins
- Viral Proteins/genetics
- Viral Proteins/immunology